ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints
Ann Intern Med
.
2011 Aug 16;155(4):JC2-4.
doi: 10.7326/0003-4819-155-4-201108160-02004.
Authors
Juan Pablo Domecq
1
,
Gabriela Prutsky
,
Victor M Montori
Affiliation
1
Universidad Peruana Cayetano Heredia, Lima, Peru.
PMID:
21844537
DOI:
10.7326/0003-4819-155-4-201108160-02004
No abstract available
Publication types
Comment